Eszopiclone Tablet, Film Coated
FDA Label NDC 0093-5537

47 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Eszopiclone (NDC 0093-5537). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: complex sleep behaviors, 1 indications and usage, 2 dosage and administration, 2.1 dosage in adults, 2.2 geriatric or debilitated patients, 2.3 patients with severe hepatic impairment, or taking potent cyp3a4 inhibitors, 2.4 use with cns depressants, 2.5 administration with food, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.